Skip to main content

Table 3 IRs and IRRs before and after the introduction of PCV7 and PCV13

From: Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England

 

N episodes

IRs per 100,000 PY (95% CI)

IRR (95% CI) vs. reference period (pre-PCV7)a

p-value

Pre-PCV7 (2003–2005)

 IPD

49

3.28 (2.42–4.33)

1

 PP

219

14.65 (12.77–16.72)

1

 ACP

2500

167.28(160.78–173.96)

1

Post-PCV7 (2007–2009)

 IPD

40

2.38 (1.70–3.25)

0.41 (0.17–1.01)

0.052

 PP

204

12.16 (10.55–13.95)

0.66 (0.44–0.99)

0.046

 ACP

3253

193.95(187.35–200.74)

1.00 (0.88–1.12)

0.945

Early post-PCV13 (2011–2014)

 IPD

34

1.68 (1.16–2.34)

0.52 (0.22–1.25)

0.143

 PP

151

7.45 (6.31–8.73)

0.47 (0.30–0.72)

0.001

 ACP

3041

150.00 (144.72–155.43)

0.98 (0.87–1.10)

0.732

Late post-PCV13 (2015–2019)

 IPD

16

1.41 (0.80–2.29)

0.28 (0.09–0.90)

0.033

 PP

44

3.87 (2.81–5.20)

0.19 (0.09–0.38)

< 0.001

 ACP

1420

124.96 (118.54–131.63)

0.77 (0.66–0.88)

< 0.001

  1. Pre-PCV7 (2004–2005). ACP All-cause Pneumonia, CI Confidence Interval, IPD Invasive Pneumococcal Disease, IR Incidence Rate, IRR Incidence Rate Ratio, N Number, PCV Pneumococcal Conjugate Vaccine, PP Pneumococcal Pneumonia, PY Person-Years